Changes in cell autophagy and apoptosis during age-related left ventricular remodeling in mice and their potential mechanisms

Biochemical and Biophysical Research Communications

Volumn 430, Issue 2, 2013, Pages 822-826

  Peng, Longyun ^a   Zhuang, Xiaodong ^a   Liao, Lizhen ^b   He, Xuyu ^a   Li, Jiaxiang ^a   Chen, Xuanlan ^a   Lu, Guihua ^a   Ma, Hong ^a   Gao, Xiuren ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Aging; Apoptosis; Autophagy; Cardiac remodeling; MAPK

Indexed keywords

BECLIN 1; CASPASE 3; HYDROXYPROLINE; MICROTUBULE ASSOCIATED PROTEIN 1; MICROTUBULE ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE 1; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOPHAGY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART INDEX; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE REMODELING; HEART VENTRICLE REMODELING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

AGE FACTORS; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CASPASE 3; HEART VENTRICLES; MALE; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; ORGAN SIZE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; VENTRICULAR REMODELING;

MUS;

EID: 84872281028     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.062     Document Type: Article

References (48)

1. Olivetti G., Melissari M., Capasso J.M., et al. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ. Res. 1991, 68:1560-1568.
2. Wanagat J., Wolff M.R., Aiken J.M. Age-associated changes in function, structure and mitochondrial genetic and enzymatic abnormalities in the Fischer 344 x Brown Norway F(1) hybrid rat heart. J. Mol. Cell. Cardiol. 2002, 34:17-28.
3. Lakatta E.G., Sollott S.J. Perspectives on mammalian cardiovascular aging: humans to molecules. Comp. Biochem. Physiol. A. Mol. Integr. Physiol. 2002, 132:699-721.
4. Hamacher-Brady A., Brady N.R., Gottlieb R.A. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J. Biol. Chem. 2006, 281:29776-29787.
5. Yan L., Vatner D.E., Kim S.J., et al. Autophagy in chronically ischemic myocardium. Proc. Natl. Acad. Sci. USA 2005, 102:13807-13812.
6. Hua Y., Zhang Y., Ceylan-Isik A.F., et al. Chronic Akt activation accentuates aging-induced cardiac hypertrophy and myocardial contractile dysfunction: role of autophagy. Basic. Res. Cardiol. 2011, 106:1173-1191.
7. Kanamori H., Takemura G., Goto K., et al. The role of autophagy emerging in postinfarction cardiac remodeling. Cardiovasc. Res. 2011, 91:330-339.
8. Boyle A.J., Shih H., Hwang J., et al. Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp. Gerontol. 2011, 46:549-559.
9. Nakai A., Yamaguchi O., Takeda T., et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 2007, 13:619-624.
10. Cuervo A.M., Bergamini E., Brunk U.T., et al. Autophagy and aging: the importance of maintaining " clean" cells. Autophagy 2005, 1:131-140.
11. Taneike M., Yamaguchi O., Nakai A., et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 2010, 6:600-606.
12. Centurione L., Antonucci A., Miscia S., et al. Age-related death-survival balance in myocardium: an immunohistochemical and biochemical study. Mech. Ageing Dev. 2002, 123:341-350.
13. Fernandes-Alnemri T., Litwack G., Alnemri E.S. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J. Biol. Chem. 1994, 269:30761-30764.
14. Tsujimoto Y., Ikegaki N., Croce C.M. Characterization of the protein product of Bcl-2, the gene involved in human follicular lymphoma. Oncogene 1987, 2:3-7.
15. Cory S., Huang D.C., Adams J.M. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003, 22:8590-8607.
16. Pearson G., Robinson F., Beers Gibson T., et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 2001, 22:153-183.
17. Choi C.H., Lee B.H., Ahn S.G., et al. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β. Biochem. Biophys. Res. Commun. 2012, 418:759-764.
18. Li C., Johnson D.E. Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation. Cancer Lett. 2012, 314:102-107.
19. de la Cruz-Morcillo M.A., Valero M.L., Callejas-Valera J.L., et al. P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance. Oncogene 2012, 31:1073-1085.
20. Tong H., Imahashi K., Steenbergen C., et al. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ. Res. 2002, 90:377-379.
21. Uchiyama T., Engelman R.M., Maulik N., et al. Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Circulation 2004, 109:3042-3049.
22. Yue T.L., Wang C., Gu J.L., et al. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ. Res. 2000, 86:692-699.
23. He X., Gao X., Peng L., et al. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7. Circ. Res. 2011, 108:164-175.
24. Alessi D.R., Andjelkovic M., Caudwell B., et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996, 15:6541-6551.
25. Boulton T.G., Nye S.H., Robbins D.J., et al. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 1991, 65:663-675.
26. Sturgill T.W., Ray L.B., Erikson E., et al. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 1988, 334:715-718.
27. Lakatta E.G., Sollott S.J. The " heartbreak" of older age. Mol. Interv. 2002, 2:431-446.
28. Lakatta E.G. Cardiovascular regulatory mechanisms in advanced age. Physiol. Rev. 1993, 73:413-467.
29. Dutta D., Calvani R., Bernabei R., et al. Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities. Circ. Res. 2012, 110:1125-1138.
30. Yamaguchi O., Otsu K. Role of autophagy in aging. J. Cardiovasc. Pharmacol. 2012, 60:242-247.
31. De Meyer G.R., De Keulenaer G.W., Martinet W. Role of autophagy in heart failure associated with aging. Heart Fail. Rev. 2010, 15:423-430.
32. Lopez-Araiza H., Ventura J.L., Lopez-Diazguerrero N.E., et al. Organ- and tissue-specific alterations in the anti-apoptotic protein Bcl-2 in CD1 female mice of different ages. Biogerontology 2006, 7:63-67.
33. Latif N., Khan M.A., Birks E., et al. Upregulation of the Bcl-2 family of proteins in end stage heart failure. J. Am. Coll. Cardiol. 2000, 35:1769-1777.
34. Clerk A., Cole S.M., Cullingford T.E., et al. Regulation of cardiac myocyte cell death. Pharmacol. Ther. 2003, 97:223-261.
35. Tanaka M., Nakae S., Terry R.D., et al. Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease. Blood 2004, 104:3789-3796.
36. Pattingre S., Tassa A., Qu X., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
37. Ravingerova T., Barancik M., Strniskova M. Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology. Mol. Cell. Biochem. 2003, 247:127-138.
38. Eom J.M., Seo M.J., Baek J.Y., et al. Alpha-eleostearic acid induces autophagy-dependent cell death through targeting AKT/mTOR and ERK1/2 signal together with the generation of reactive oxygen species. Biochem. Biophys. Res. Commun. 2010, 391:903-908.
39. Lou H., Kaur K., Sharma A.K., et al. Adriamycin-induced oxidative stress, activation of MAP kinases and apoptosis in isolated cardiomyocytes. Pathophysiology 2006, 13:103-109.
40. Peart J.N., Gross E.R., Headrick J.P., et al. Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection. J. Mol. Cell. Cardiol. 2007, 42:972-980.
41. Takeishi Y., Huang Q., Abe J., et al. Activation of mitogen-activated protein kinases and p90 ribosomal S6 kinase in failing human hearts with dilated cardiomyopathy. Cardiovasc. Res. 2002, 53:131-137.
42. Tenhunen O., Soini Y., Ilves M., et al. P38 Kinase rescues failing myocardium after myocardial infarction: evidence for angiogenic and anti-apoptotic mechanisms. FASEB J. 2006, 20:1907-1909.
43. Martindale J.J., Wall J.A., Martinez-Longoria D.M., et al. Overexpression of mitogen-activated protein kinase kinase 6 in the heart improves functional recovery from ischemia in vitro and protects against myocardial infarction in vivo. J. Biol. Chem. 2005, 280:669-676.
44. Nishida K., Yamaguchi O., Hirotani S., et al. P38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol. Cell. Biol. 2004, 24:10611-10620.
45. Hausenloy D.J., Yellon D.M. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc. Res. 2006, 70:240-253.
46. Kaga S., Zhan L., Altaf E., et al. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J. Mol. Cell. Cardiol. 2006, 40:138-147.
47. Huang C., Yitzhaki S., Perry C.N., et al. Autophagy induced by ischemic preconditioning is essential for cardioprotection. J. Cardiovasc. Transl. Res. 2010, 3:365-373.
48. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136.